| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692682 | The Breast | 2017 | 6 Pages |
Abstract
Our experience confirmed the wide heterogeneity of DCIS. Inadequate FSM and negative ER status negatively influenced LR rates. Tumor biology should be integrated in adjuvant treatment decision-making process.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Icro MD, Calogero Saieva, Paolo Bastiani, Francesca Martella, Giulio Francolini, Monica lo Russo, Lisa Paoletti, Morena Doria, Isacco Desideri, Francesca Terziani, Carla De Luca Cardillo, Benedetta Bendinelli, Cinzia Ciabatti, Cristina Muntoni,